Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer

NCT00783172 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Problems with IRB

Conditions

Pancreatic Cancer

Interventions

DRUG: Gemcitabine
BIOLOGICAL: Opioid Growth Factor (OGF)

Sponsor

Milton S. Hershey Medical Center

Collaborators

[object Object]
[object Object]